Scinai Immunotherapeutics (SCNI) Change in Cash (2018 - 2024)

Scinai Immunotherapeutics has disclosed Change in Cash across 7 years of filings, most recently posting $926000.0 for Q4 2024.

• Change in Cash for Q4 2024 came in at $926000.0, up 162.86% year-over-year; the trailing twelve-month figure through Dec 2024 was -$3.6 million (up 60.67% YoY), and the FY2025 annual result was -$284000.0, up 90.26% from the prior year.
• Change in Cash came in at $926000.0 for Q4 2024 at Scinai Immunotherapeutics, up from -$1.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $11.7 million in Q1 2021 to a low of -$15.4 million in Q4 2020.
• The 5-year median for Change in Cash is -$3.0 million (2022), against an average of -$2.8 million.
• Across the five-year window, Change in Cash sank 452.27% in 2020 and surged 162.86% in 2024, its largest moves.
• Scinai Immunotherapeutics' Change in Cash stood at -$15.4 million in 2020, then soared by 143.12% to $6.6 million in 2021, then decreased by 12.96% to $5.8 million in 2022, then tumbled by 125.56% to -$1.5 million in 2023, then soared by 162.86% to $926000.0 in 2024.
• The last three Change in Cash figures came in at $926000.0 (Q4 2024), -$1.9 million (Q3 2024), and -$1.5 million (Q4 2023), per Business Quant data.